DCOY

NASD Decoy Therapeutics Inc.

Nov 10, 2026 · 1:19 PM ET DELAYED Market Open

$1.14 ↑ +0.04 (+3.64%) Trading Up from the previous close of $1.10, $0.01 below the day’s high of $1.15

YTD change: -87.66%
vs 20-day SMA: +2.84%
vs 200-day SMA: -78.29%

Price ranges

Previous day

$0.99 $1.12

open $1.04 close $1.10

+$0.06 (+5.77%)

Today

$1.00 $1.15

open $1.10 now $1.14

+$0.04 (+3.64%)

Past week

$0.99 $1.15

from $1.04 now $1.14

+$0.11 (+10.14%)

Past month

$0.90 $1.43

from $1.43 now $1.14

-$0.29 (-20.28%)

This year

$0.53 $13.51

from $9.24 now $1.14

-$8.10 (-87.66%)

Price & Performance

-4.34 (-79.78%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 97.0% away from all-time highs of $38.40
DCOY is down 88% since the beginning of the year
DCOY is down 88% over the past 12 months
DCOY is down 20% over the past 1 month
4% of all DCOY investors are betting against DCOY

DCOY reads neutral: price sits above one of the two key moving averages, the 12-month move is +42.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-4.46

Earnings momentum -72.2% Quarterly EPS growth

Quarterly change -72.2%

Valuation

P/E ratio N/A

Enterprise value $-7703940.0

Beta 1.85

Balance sheet & scale

IncomeN/A

Revenue$227.6K

Cash$8.3M

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $2.6M

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

Competitor comparison

Ticker	Company	Price	Change
REGN	Regeneron Pharmaceuticals, Inc.	$919.96	+1.73%
IQV	IQVIA Holdings Inc	$278.84	+2.58%
CRL	Charles River Laboratories International, Inc.	$353.34	+4.69%
ICLR	ICON Plc	$207.59	+1.39%
IT	Gartner, Inc.	$191.02	+0.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.